Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C
- 1 November 2007
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 28 (3), 370-376
- https://doi.org/10.1111/j.1478-3231.2007.01608.x
Abstract
Background/Aim: Both steatosis and insulin resistance have been linked to accelerated fibrosis in chronic hepatitis C. Connective tissue growth factor (CTGF) plays a major role in extracellular matrix production in fibrotic disorders including cirrhosis, and its expression is stimulated in vitro by insulin and glucose. We hypothesized that CTGF may link steatosis, insulin resistance and fibrosis. Methods: We included 153 chronic hepatitis C patients enrolled in the Swiss Hepatitis C Cohort Study and for whom a liver biopsy and plasma samples were available. CTGF expression was assessed quantitatively by immunohistochemistry. In 94 patients (57 with genotypes non‐3), plasma levels of glucose, insulin and leptin were also measured. CTGF synthesis was investigated by immunoblotting on LX‐2 stellate cells. Results: Connective tissue growth factor expression was higher in patients with steatosis (P=0.039) and in patients with fibrosis (P=0.008) than those without these features. CTGF levels were neither associated with insulinaemia or with glycaemia, nor with inflammation. By multiple regression analysis, CTGF levels were independently associated with steatosis, a past history of alcohol abuse, plasma leptin and HCV RNA levels; when only patients with genotypes non‐3 were considered, CTGF levels were independently associated with a past history of alcohol abuse, plasma leptin levels and steatosis. Leptin stimulated CTGF synthesis in LX‐2 cells. Conclusions: In patients with chronic hepatitis C and steatosis, CTGF may promote fibrosis independently of inflammation. CTGF may link steatosis and fibrosis via increased leptin levels.Keywords
This publication has 38 references indexed in Scilit:
- Connective Tissue Growth Factor in Serum as a New Candidate Test for Assessment of Hepatic FibrosisClinical Chemistry, 2006
- Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cellsHepatology, 2005
- HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-β1Experimental & Molecular Medicine, 2005
- Leptin and connective tissue growth factor in advanced glycation end‐product‐induced effects in NRK‐49F cellsJournal of Cellular Biochemistry, 2004
- The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patientsJournal of Hepatology, 2004
- The severity of liver fibrosis is associated with high leptin levels in chronic Hepatitis CJournal of Viral Hepatitis, 2004
- Expression of Leptin and Leptin Receptor During the Development of Liver Fibrosis and CirrhosisExperimental and Clinical Endocrinology & Diabetes, 2004
- Fibrogenic impact of high serum glucose in chro nic hepatitis CJournal of Hepatology, 2003
- Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis CHepatology, 2003
- The Connective Tissue Growth Factor/Cysteine- Rich 61/Nephroblastoma Overexpressed (CCN) FamilyEndocrine Reviews, 1999